Literature DB >> 17608816

Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy.

Peter Igaz, Katalin Müllner, Beáta Hargitai, Ivan Igaz, Zsófia Tömböl, Károly Rácz, Zsolt Tulassay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17608816     DOI： 10.1111/j.1365-2265.2007.02957.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  3 in total

1.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

2.  Serum chromogranin A levels for the diagnosis and follow-up of well-differentiated non-functioning neuroendocrine tumors.

Authors:  Yuejuan Cheng; Zhao Sun; Chunmei Bai; Xiaoyan Yan; Ran Qin; Changting Meng; Hongyan Ying
Journal:  Tumour Biol       Date:  2015-09-26

3.  Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma.

Authors:  Usman Hammawa Malabu; Rozemary Karamatic; Gillian Mahy; Kunwarjit Singh Sangla
Journal:  Case Rep Endocrinol       Date:  2011-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.